Economics of obesity - learning from the past to contribute to a better future by Ananthapavan, Jaithri et al.
	 	
	
 
 
This is the published version:  
 
Ananthapavan,	Jaithri,	Sacks,	Gary,	Moodie,	Marj	and	Carter,	Rob	2014,	Economics	of	obesity	‐	
learning	from	the	past	to	contribute	to	a	better	future,	International	journal	of	environmental	
research	and	public	health,	vol.	11,	no.	4,	pp.	4007‐4025.	
	
	
Available from Deakin Research Online: 
 
http://hdl.handle.net/10536/DRO/DU:30062485	
	
	
	
Reproduced	with	the	kind	permission	of	the	copyright	owner.		
	
Copyright	:	2014,	M	D	P	I	AG	
Int. J. Environ. Res. Public Health 2014, 11, 4007-4025; doi:10.3390/ijerph110404007 
 
International Journal of 
Environmental Research and 
Public Health 
ISSN 1660-4601 
www.mdpi.com/journal/ijerph 
Article 
Economics of Obesity — Learning from the Past to Contribute 
to a Better Future 
Jaithri Ananthapavan 1,*, Gary Sacks 2, Marj Moodie 1 and Rob Carter 1 
1 Deakin Health Economics, Faculty of Health, Deakin University, 221 Burwood Highway, 
Burwood, Victoria 3125, Australia; E-Mails: marj.moodie@deakin.edu.au (M.M.); 
rob.carter@deakin.edu.au (R.C.) 
2 WHO Collaborating Centre for Obesity Prevention, Faculty of Health, Deakin University,  
221 Burwood Highway, Burwood, Victoria 3125, Australia; E-Mail: gary.sacks@deakin.edu.au 
* Author to whom correspondence should be addressed; E-Mail: jaithri.ananthapavan@deakin.edu.au;  
Tel.: +61-3-9251-7181; Fax: +61-3-9244-6624. 
Received: 1 February 2014; in revised form: 28 March 2014 / Accepted: 28 March 2014 /  
Published: 14 April 2014 
 
Abstract: The discipline of economics plays a varied role in informing the understanding 
of the problem of obesity and the impact of different interventions aimed at addressing it. 
This paper discusses the causes of the obesity epidemic from an economics perspective, 
and outlines various justifications for government intervention in this area. The paper then 
focuses on the potential contribution of health economics in supporting resource allocation 
decision making for obesity prevention/treatment. Although economic evaluations of single 
interventions provide useful information, evaluations undertaken as part of a priority 
setting exercise provide the greatest scope for influencing decision making. A review of 
several priority setting examples in obesity prevention/treatment indicates that policy  
(as compared with program-based) interventions, targeted at prevention (as compared with 
treatment) and focused “upstream” on the food environment, are likely to be the most  
cost-effective options for change. However, in order to further support decision makers, 
several methodological advances are required. These include the incorporation of 
intervention costs/benefits outside the health sector, the addressing of equity impacts,  
and the increased engagement of decision makers in the priority setting process. 
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1. Introduction 
The global obesity epidemic and its impact on global morbidity and mortality have been well 
reported [1–3]. Overweight and obesity have been steadily increasing globally over the last 30 years, 
and in many countries, such as Australia, elevated Body Mass Index (BMI) has overtaken high blood 
pressure and smoking to become the leading risk factor contributing to the burden of disease 
(responsible for 8.3% of the total Australian disease burden in 2010) [4]. 
The goals of managing the obesity epidemic and potentially reversing it are hinged on interdisciplinary 
collaborative efforts in research, policy development and intervention implementation by professionals 
from diverse disciplines and service sectors. One such discipline is health economics, which plays a 
varied role in both understanding the problem of obesity and in evaluating efforts to treat and prevent 
it. The aims of this paper are to review the potential contribution of health economics in understanding 
the problem of obesity and possible solutions. We also aim to outline the lessons learnt from priority 
setting studies in this area, review the gaps in the cost-effectiveness evidence base, and suggest areas 
for future research. 
2. Overview of the Economics of Obesity 
Whilst obesity can be viewed as a simple imbalance between caloric intake and expenditure,  
several authors have drawn on theoretical and empirical economic evidence to explain both the 
individual choices leading to a caloric surplus and the environmental factors that encourage such 
choices [5–8]. Economic growth, a fundamental macro-economic objective, has been described as a 
systemic driver of the obesity epidemic [1,9]. The quest for sustained and higher levels of economic 
growth is underpinned by increased consumption of goods and services; including food, beverages and 
energy saving devices. Eggers and colleagues [10] argue that although economic growth is a key factor 
which lifts low income countries out of poverty and is positively correlated with improved population 
health, a country’s gross domestic product (GDP) ultimately appears to increase beyond the optimal 
level (“sweet spot”) and produces diminishing marginal returns on health. Economic growth beyond 
the presumed sweet spot is hypothesised to result in the transition from populations experiencing high 
mortality associated with infectious (communicable) diseases to mortality and morbidity associated 
with chronic (and non-communicable) disease caused by overconsumption [9,10]. 
Similarly, while the notion of “consumer sovereignty” and the essential role of markets pervades 
orthodox economic thinking (i.e., individuals are well placed to decide on the food they consume and 
their physical activity), it is now increasingly recognised that people are driven to become more 
overweight and obese as a result of the obesogenic environment in which they live [1,6,7].  
The increased production of cheap, tasty, energy-dense food, together with improved food distribution 
and highly pervasive and persuasive marketing, creates a “push effect” that drives over consumption of 
calories [1]. In this highly complex food environment, many of the choices people make are outside 
individual awareness leading people to consume excess energy without even realising it  
(so called, passive overconsumption) [11]. For physical activity, the environment has been described  
as a moderator which acts to amplify or attenuate the impact of the obesity drivers [1].  
Urbanisation, built environments and technological advances have changed the nature of workplaces, 
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the transport system, and the opportunities for physical activity. In addition, the increased opportunity 
cost associated with undertaking physical activity during scarce leisure time has contributed to 
increasingly sedentary lifestyles [1,7,8]. Thus with regard to both food choices and physical activity,  
it is unlikely that the obesity epidemic is due to informed individual preference. It follows therefore, 
that unless there are fundamental changes to the obesogenic environment, the epidemic is unlikely to 
diminish. This takes us to economic thinking about the basis for government intervention. 
There is evidence that the level of obesity varies amongst market-based capitalist countries,  
and that those with greater government regulation of markets, higher social welfare spending and more 
equitable distribution of wealth generally benefit from lower levels of obesity prevalence [10].  
Whilst such “ecological” data is interesting, most economists would nonetheless want to see the 
economic rationale for government intervention. Economic reasoning would focus on the case for 
“market failure”, together with the existence of any evidence to suggest that government intervention 
would be effective and not result in “government failure”. Examples of market failure include 
imperfect information, externalities (impacts not internalised in market prices), monopoly power and 
irrational individual behaviour [12]. There is evidence that all of these factors exist in the case of 
obesity. The ubiquitous marketing environment that influences human behaviour in order to achieve 
higher company profits, makes it difficult for individuals to make optimal choices in terms of their 
health [7,12]. In Australia in 2005, the total annual healthcare cost of overweight and obesity was 
estimated to be approximately AUD 21 billion [13]. These significant healthcare costs are a  
“negative externality” as the costs are borne by everyone in society through the national universal tax 
funded health insurance scheme and are not limited to those who are themselves overweight or obese.  
Another potential justification for government intervention is to protect consumers who act irrationally 
by prioritising short term gratification from excess calorie consumption, over longer term impacts on 
health [1,5,12]. However, as described above, it is more likely that over-consumption is driven by 
environmental factors than irrational behaviour. The economic rationale for government intervention is 
stronger in relation to interventions aimed at preventing obesity in children who make consumption 
choices despite the high level of information asymmetry and their diminished ability to consider the 
future consequences of their poor food choices [1,5,12]. Hale and colleagues [14] also make an 
economic case for government intervention for prevention and health promotion activities based on the 
fact that health information is a “public good” and is therefore likely to be undersupplied by the market. 
Establishing the case for market failure is a “necessary but not sufficient condition” from an 
economic perspective to justify government action. Economists have long been concerned that in 
intervening, governments may distort markets, have unintended consequences, or that their actions 
may simply not work. The development of the decision sciences, including economic evaluation,  
can be traced to this concern to assist policy formation. In the case of economic appraisal, the rationale 
is to establish that government intervention constitutes “value-for-money” in the use of limited 
government resources. The notion of “value” is the central construct here. The definition and 
measurement of value is both a technical matter (which form of economic appraisal to use) and an 
important ethical matter. Over and above matters of market failure, governments are conscious of the 
“rights of citizenship” and often take action to ensure access to services that economists call  
“merit goods”, such as education and health care. In fact, many economists would concede that 
governments are more likely to intervene initially on the basis of social justice concerns, and then use 
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market failure/government failure arguments to sort out the detail. Such social justice concerns become 
more compelling when the protection of vulnerable members of society are involved. This is evidenced  
by public support for government intervention to address the growing rates of obesity amongst 
children [15–17]. 
3. The Contribution of Health Economics 
If government intervention to change the obesogenic environment is justified, how can the 
discipline of health economics make a significant contribution? Aiming to address the question of how 
to allocate scarce resources to maximise society’s welfare, economists undertake studies that describe, 
predict, explain and evaluate the current situation and possible alternatives [18]. Cost of illness (COI) 
studies describe the economic costs of obesity by estimating the healthcare costs and costs of lost 
productivity attributable to obesity. Over the last 20 years, the volume of cost of obesity publications 
has grown and there are now several reviews of such studies in specific populations, such as subgroups 
of different ages, sex, socio-economic status (SES) and co-morbidities [19–22]. Burden of disease 
(BoD) and COI studies are useful in quantifying the disease and cost burden of obesity and, therefore, 
highlighting the need for action. However, there are several limitations to COI/BoD studies that 
generally preclude them from providing sufficient evidence to support resource allocation decision 
making, largely due to their focus on the cost or health burden of disease, rather than on comparing 
potential solutions [21]. Therefore, unless integrated with economic evaluations of the options for 
change, the role of COI/BoD studies is limited to describing the problem of obesity, and provides little 
guidance on solutions to the problem [19,21]. 
A solutions-based approach to obesity prevention and treatment (referred to as obesity management 
hereafter) requires high quality, full economic evaluation studies which use explicit methods to inform 
which interventions are both effective and offer value-for-money [18]. Economic evaluations provide 
answers to the policy question—what are the additional benefits of funding an intervention relative to 
its costs. The results are expressed as the net cost per unit of benefit. Results from full economic 
evaluations allow decision makers to make an informed judgement based on the incremental  
cost of implementing the intervention relative to the potential benefits foregone by maintaining  
the status quo [23,24]. 
The availability of economic evaluation evidence to guide obesity policy is varied. Certain clinical 
interventions such as pharmaceutical management of obesity and bariatric surgery have been the topic 
of several economic evaluations with reviews reporting over twenty-seven economic evaluations of 
these interventions [25,26]. However there are other categories of obesity interventions that have had 
little attention in terms of evaluation. A recent systematic review of obesity management interventions 
aimed at pre-school children found that there were no economic evaluations published covering  
this topic [27]. A review of economic evaluations of fiscal policies to prevent obesity found that only 
three full economic evaluations have been undertaken in recent years [28]. 
There are several reasons for the paucity of economic evaluations for some types of obesity 
interventions and abundance in others. Firstly, an essential component of an economic evaluation is the 
evidence base around an intervention’s effectiveness. Interventions aimed at treating obesity through 
the use of pharmaceuticals or bariatric surgery are more suitable for evaluation using gold standard 
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methods such as randomised controlled trials (RCTs). In contrast, policy interventions such as fiscal 
measures are complex and trial-based studies are less feasible to conduct [6]. Treatment options are 
also better positioned to demonstrate efficacy results with short to medium term follow up.  
On the other hand, interventions aimed at obesity prevention are often more complex due to the 
contribution of the multiple causal factors and are likely to take much longer to show benefits. 
Therefore short term summative evaluations, undertaken before the intervention has “matured” will not 
adequately demonstrate their true effectiveness [29]; and hence are less likely to be published [30]. 
Another reason for the relatively large volume of literature pertaining to clinical interventions is 
possibly related to the commercial interest of publishing the positive results of certain treatment 
options such as pharmaceuticals and medical devices used in obesity surgery. Industry sponsored 
studies have stringent requirements for approval and therefore commercial success, hence these studies 
are also more likely to have higher budgets and may be of superior design quality [31]. 
4. Priority Setting Obesity Interventions—What is the Current Evidence? 
Single intervention evaluations provide information to decision makers faced with one choice—to 
fund or modify a specific intervention or maintain the status quo. However, they provide little insight 
into the prioritising of a suite of potential interventions. For example, Australian decision makers 
tasked with allocating scarce resources with the aim of reducing obesity prevalence are unlikely to be 
able to make a decision of whether or not to publicly fund bariatric surgery based on the cost-effectiveness 
results of bariatric surgery compared to no surgery. Whilst cost-effectiveness results of a single 
intervention are useful, decision makers are faced with a myriad of other questions: are the results 
transferable from the evaluation setting to the Australian healthcare setting; will the cost-effectiveness 
results change when the trial based intervention is scaled up to the population level; are there other 
interventions, such as community prevention interventions, that are more cost-effective than bariatric 
surgery at the population level; and will the decision to fund bariatric surgery be politically and 
practically feasible to implement? Single intervention evaluations are therefore limited in their ability 
to inform priority setting decision making [32]. 
In order to make an impact on the strategic direction of policy related to population obesity 
management, decision makers require a systematic and explicit approach to priority setting which is 
fair and evidence-based [33]. Health economics can make a significant contribution to this through the 
conduct of studies that provide data on the cost-effectiveness of a suite of interventions which have 
been evaluated using consistent methods within the same decision making context. The technical 
results of such evaluations need to be considered within a decision-making framework which explicitly 
considers other factors of importance to decision makers such as “equity” and “feasibility of 
implementation”. There is no “gold standard” when it comes to priority setting methodology and 
several approaches have been trialed [32–35]. The following section reviews evidence from four 
priority setting exercises related to obesity management—Assessing Cost-Effectiveness (ACE) in 
Obesity, ACE—Prevention, a component of the Pacific Obesity Prevention in Communities (OPIC) 
project and a joint initiative by the Organisation for Economic Co-operation and Development (OECD) 
and the World Health Organisation (WHO). 
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The ACE methodology [32] has been used in ACE‒Obesity and ACE‒Prevention, which are 
examples of priority setting studies related to obesity management in the Australian context.  
The methods and results from these studies have been published elsewhere [36–48]. ACE-Obesity and 
ACE-Prevention were the first studies in Australia to conduct a systematic evaluation of obesity 
interventions within a priority setting context with the specific aim of providing the relevant 
information required by government decision makers [36,38,39]. The ACE methodology aims to 
combine the two main requirements for policy decision making and priority setting—the application of 
decision rules with a focus on technical rigour, together with due process, where rational decisions are 
made following debate and consensus building amongst key stakeholders [32,37]. A key characteristic 
of the ACE methodology is the use of a standardised evaluation protocol (common reference year, 
perspective, timeframe, target population and methods for measuring costs and benefits, etc.) for all 
interventions [32,37]. Other key aspects of the ACE methodology are the inclusion of a representative 
group of stakeholders who are involved in all aspects of the project, and the two-stage assessment of 
benefit where the technical cost-effectiveness results are considered alongside other considerations 
(referred to as “second-stage filters”) of importance to decision makers (such as equity, feasibility of 
implementation, affordability, acceptability, sustainability, strength of evidence and potential for  
side effects) [32,36]. 
The ACE-Obesity study evaluated the 13 most relevant interventions to government decision 
makers related to obesity management in children and adolescents [36]. The ACE-Prevention study 
investigated 150 interventions aimed primarily at preventing (127 interventions) but also treating  
(23 interventions) non-communicable diseases. Of these 150 interventions, nine interventions related 
to obesity management [39]. A review of the outcomes from the ACE studies can help generate 
knowledge of the characteristics of obesity management interventions that determine their  
cost-effectiveness profile. The main findings are outlined below in Tables 1–3. In accordance with the 
commonly used benchmark in Australia, a decision threshold of “AUD 50,000 per disability adjusted 
life year (DALY) averted” was used to determine the cost-effectiveness of interventions. 
4.1. Prevention vs. Treatment 
There were eleven treatment/targeted secondary prevention interventions investigated in the ACE 
studies, with over half of them being cost-effective. Whilst targeted treatment was shown to be 
relatively costly, it was effective in inducing weight loss. There were also two interventions that were 
cost-saving, both of which targeted overweight or obese children [38]. This demonstrates that there 
were several value-for-money treatment options for overweight and obese children and adults in 
Australia. The exceptions were the Weight Watchers program and the use of pharmacotherapy for 
obesity treatment in adults, which were not cost-effective with ICERs of approximately AUD 84,000 
and AUD 200,000 per DALY averted respectively [39,48]. The pharmacotherapy results for adults 
differed to the results for orlistat in adolescents, which reported a net ICER of approximately  
AUD 8,000 per DALY [38]. This reflects the different target groups (adults verses adolescents) and the 
differing assumptions made by the respective ACE Working Groups on decay effects and the 
associated regain of weight loss [48]. 
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Table 1. Cost-effectiveness of primary prevention versus treatment (and secondary 
prevention) interventions from the Assessing Cost-Effectiveness (ACE)-Obesity and  
ACE-Prevention studies. 
Cost-effectiveness Intervention Classification ≠ 
Cost-saving † 
Treatment (and Secondary Prevention) Primary Prevention 
Family-based General Practitioner (GP) 
programme targeted at obese children [38] 
Multi-faceted targeted school-based 
programme for overweight and obese 
children [38] 
School (curriculum)-based education programme to 
reduce television viewing [38] 
Multi-faceted school (curriculum)-based 
programme including nutrition and  
physical activity [38] 
School-based education programme to reduce 
sugar-sweetened drink consumption [38] 
Reduction of advertising of unhealthy food and 
beverages to children [43] 
Front-of-pack traffic light nutrition labelling [47] 
Unhealthy food and beverage tax (10%) [47] 
Cost-effective ‡ 
(ICER ≤ 
$50,000/DALY) 
Orlistat (obese adolescents µ) [38] 
Family-based GP programme targeted at 
overweight and moderately obese  
children [45] 
Laparoscopic adjustable gastric banding 
(LAGB) for obese adults (BMI > 35) β [42] 
LAGB for obese adolescents [40] 
Diet and exercise for adults BMI > 25 [41] 
Low-fat diet for adults BMI > 25 [41] 
Multi-faceted school (curriculum)-based 
programme without an active physical  
activity component [38] 
Not cost-effective ∫ 
(ICER > 
$50,000/DALY) 
Sibutramine (obese adults) * [48] 
Orlistat (obese adults) [48] 
Weight watchers [39] 
Walking school bus [44] 
TravelSMART schools α [46] 
Active after schools communities program [49] 
Lighten up to a healthy lifestyle weight-loss 
programme for adults π [39] 
Notes: ≠ The costs included in the economic analyses are the costs of intervention implementation,  
delivery and the healthcare ramification costs or cost offsets. Productivity costs have not been included.  
† Interventions with net cost-effectiveness results (includes cost offsets) which are cost-saving.  
‡ Interventions with incremental cost-effectiveness ratios (ICER) below the threshold value of AUD 50,000 
per DALY averted. ∫ Interventions with ICER above the threshold value of AUD 50,000 per DALY averted.  
µ Orlistat is restricted for use in adults only in Australia. β Results were cost-saving when the intervention was 
targeted at obese adults with BMI > 40. * Withdrawn from Australian in 2010. α School and community 
based intervention aimed to increase active transport. π Although not restricted/targeted, the majority of 
participants were overweight or obese. 
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Table 2. Cost-effectiveness of program versus policy interventions from the Assessing 
Cost-Effectiveness (ACE)-Obesity and ACE-Prevention studies. 
Cost-effectiveness Intervention Classification ≠ 
Cost-saving † 
Program Policy 
Family-based GP programme targeted at 
obese children [38] 
School-based education programme to 
reduce sugar-sweetened  
drink consumption [38] 
Multi-faceted targeted school-based 
programme for overweight and obese 
children [38] 
School (curriculum)-based education programme 
to reduce television viewing [38] 
Multi-faceted school (curriculum)-based 
programme including nutrition and  
physical activity [38] 
Reduction of advertising of unhealthy food and 
beverages to children [43] 
Front-of-pack traffic light nutrition labelling [47]
Unhealthy food and beverage tax (10%) [47] 
Cost-effective ‡ 
(ICER ≤ 
$50,000/DALY) 
Family-based GP programme targeted at 
overweight and moderately obese  
children [45] 
Diet and exercise for adults with Body 
Mass Index (BMI) > 25 [41] 
Low-fat diet for adults BMI > 25 [41] 
Multi-faceted school (curriculum)-based 
programme without an active physical  
activity component [38] 
Not cost-effective ∫ 
(ICER>$50,000/DALY) 
Walking school bus [44] 
TravelSMART schools α [46] 
Active after schools communities  
program [49] 
Lighten up to a healthy lifestyle weight-loss 
programme for adults π [39] 
Weight watchers [39] 
 
Notes: ≠ The costs included in the economic analyses are the costs of intervention implementation,  
delivery and the healthcare ramification costs or cost offsets. Productivity costs have not been included. 
Individualised treatment interventions (e.g., Laparoscopic adjustable gastric banding and pharmacotherapy) 
have not been included in this table. † Interventions with net cost-effectiveness results (includes cost offsets) 
which are cost-saving. ‡ Interventions with incremental cost-effectiveness ratios (ICER) below the threshold 
value of AUD 50,000 per DALY averted. ∫ Interventions with ICER above the threshold value of AUD 
50,000 per DALY averted. α School and community based intervention aimed to increase active transport.  
π Although not restricted/targeted, the majority of participants were overweight or obese. 
On the other hand, the majority of primary preventive interventions in Table 1 targeting both 
children and adults were shown to be cost-saving. This suggests that, compared to treatment, 
preventive interventions were better options for the management of obesity in the long term.  
However there were also non cost-effective preventive interventions. Factors that resulted in 
preventive interventions being non cost-effective included the design of interventions not being 
specifically aimed at obesity prevention—for example, the active transport based interventions were 
designed to increase the number of children walking to school and to provide a safer traffic 
environment around schools [44,46]. This highlights a limitation of the application of the ACE 
methodology in ACE-Obesity and ACE-Prevention, where the benefits of an intervention independent 
of changes in weight were not captured [50]. 
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Table 3. Cost-effectiveness of interventions aimed at food intake and physical activity 
from the Assessing Cost-Effectiveness (ACE)-Obesity and ACE-Prevention studies. 
Cost-effectiveness Intervention Classification ≠ 
Cost-saving † 
Food Intake Physical Activity Food Intake & Physical Activity 
School-based education 
programme to reduce  
sugar-sweetened  
drink consumption [38] 
Reduction of advertising of 
unhealthy food and beverages  
to children [43] 
Front-of-pack traffic light  
nutrition labelling [47] 
Unhealthy food and beverage  
tax (10%) [47] 
 
School (curriculum)-based  
education programme to reduce  
television viewing [38] 
Multi-faceted school (curriculum)-based 
programme including nutrition and 
physical activity [38] 
Family-based GP programme targeted at 
obese children [38] 
Multi-faceted targeted school-based 
programme for overweight and  
obese children [38] 
Cost-effective ‡ 
(ICER ≤ 
$50,000/DALY) 
Orlistat (obese adolescents µ) [38] 
Laparoscopic adjustable gastric for 
obese adults (BMI > 35) β [42] 
Laparoscopic adjustable gastric for 
obese adolescents [40] 
Low-fat diet for adults  
BMI > 25 [41] 
 
Family-based GP programme targeted at 
overweight and moderately  
obese children [45] 
Multi-faceted school (curriculum)-based 
programme without an active  
physical activity component  
(this intervention included education  
on physical activity) [38] 
Diet and exercise for adults BMI > 25 [41]
Not cost-effective ∫ 
(ICER > 
$50,000/DALY) 
Sibutramine (obese adults) * [48] 
Orlistat (obese adults) [48] 
Walking school 
bus [44] 
TravelSMART 
schools α [46] 
Active after 
schools 
communities 
program [49] 
Lighten up to a healthy lifestyle  
weight-loss programme for adults π [39] 
Weight Watchers [39] 
Notes: ≠ The costs included in the economic analyses are the costs of intervention implementation,  
delivery and the healthcare ramification costs or cost offsets. Productivity costs have not been included.  
† Interventions with net cost-effectiveness results (includes cost offsets) which are cost-saving.  
‡ Interventions with incremental cost-effectiveness ratios (ICER) below the threshold value of AUD 50,000 
per DALY averted. ∫ Interventions with ICER above the threshold value of AUD 50,000 per DALY averted.  
µ Orlistat is restricted for use in adults only in Australia. β Results were cost-saving when the intervention was 
targeted at obese adults with BMI > 40. * Withdrawn from Australian in 2010. α School and community 
based intervention aimed to increase active transport. π Although not restricted/targeted, the majority of 
participants were overweight or obese. 
4.2. Program vs. Policy 
The ACE interventions can also be classified as program or policy. Although the distinction 
between these two is not clear by definition, for practical purposes, policies can be defined by the 
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policy instruments available to governments such as laws, regulations, taxes and services [51].  
In contrast, programs can be defined as locally co-ordinated efforts implemented in specific sectors 
which are additional to the usual business of those sectors. Using this definition, the implementation of 
programs usually entails additional skills, services and funding. 
The majority of policy interventions were cost-saving and all of the policy interventions evaluated 
had a net ICER below AUD 6,000 per DALY, well below the accepted cost-effectiveness threshold [38]. 
On the other hand, the program based interventions ranged from being cost-saving to being not  
cost-effective (Table 2). Policy interventions were usually more sustainable than programs.  
Programs were generally reliant on ongoing support funding, and therefore their long term 
sustainability influenced their cost-effectiveness profile. The affordability of programs is also 
dependent on the budget constraints of the program setting. For example, school based interventions 
which utilised regular teachers were more affordable and sustainable, and once implemented in the 
curriculum could be considered a policy rather than a program that required ongoing support by 
specialised staff. 
4.3. Food vs. Physical Activity 
With the aim of preventing or treating obesity, interventions can either have an impact on calorie 
intake, expenditure or both. Table 3 shows the ACE interventions categorised according to their impact 
on the different sides of the “energy balance equation”. The majority of interventions that targeted 
food intake only (80%) or both food intake and physical activity (78%) were either cost-effective or 
cost-saving. On the other hand, interventions which only targeted physical activity were found to be 
not cost-effective. This is likely related to the limited number and scope of the specific interventions 
related to physical activity evaluated in the previous ACE projects. Most commonly,  
policy interventions targeting physical activity are more difficult to evaluate due to the difficulty in 
gathering conclusive evidence on effectiveness. 
The majority of physical activity targeted interventions from ACE-Obesity were in the school 
setting and required additional staff for implementation which affected the sustainability and  
cost-effectiveness profile [44,46,49]. However, there is some preliminary evidence from a current 
American priority setting study, which indicates that certain school based policy interventions 
targeting the intensity of physical activity can be cost-saving when implemented without the need for 
additional resources [52]. 
Another limitation of the physical activity interventions evaluated in the ACE projects was the lack 
of built environment interventions designed to encourage more physical activity (e.g., bike paths). 
Despite their limitations, the results from ACE-Obesity and ACE-Prevention are consistent with the 
view that the food environment is a key driver and has a greater impact on the development and 
therefore the management of obesity compared to the physical activity environment which is a 
moderator of the drivers of the obesity epidemic [1]. 
The cost-effectiveness results from the ACE projects from Tables 1–3 indicate that there are several 
value-for-money options for the management of obesity; however to date, there is limited evidence of 
implementation of even the most cost-effective interventions. A review of the “second stage filters” 
from these studies demonstrates that the majority of these interventions had significant impacts on the 
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equity, acceptability and/or feasibility filters [38,43]. This reinforces the need to create a strong 
“political will for change” if interventions that are currently deemed not acceptable to influential 
stakeholders are to be implemented. Another reason for lack of policy action on cost-effective 
interventions could be the “partial analysis” methodology of the ACE evaluations (i.e., only health 
related outcomes were considered) [51]. Results from partial analyses may be less compelling to 
decision makers, particularly those outside the health care sector. 
4.4. Other Priority Setting Studies in Obesity Prevention 
There have been several other examples of priority setting of obesity interventions. Within the 
broader OPIC project on adolescent obesity in the Pacific region, a priority setting exercise was 
undertaken with the aim of facilitating evidence-based decision making by policy makers in Fiji and 
Tonga [53]. The study specifically focused on food policies that were specific to the local context, and 
modelled the impact of these policies on deaths averted due to non-communicable diseases. In the 
Fijian context, the five most cost-effective options were fiscal policies related to import duties and 
value-added-tax. In Tonga, the most cost-effective options were also predominantly related to food 
prices but also included policies related to food availability. Some of the interventions that were 
prioritised in the OPIC study have been translated into national policy and are in the process of being 
implemented. The key lessons from this priority setting study are the importance of considering the 
local food environment and the decision making context when prioritising obesity management 
interventions [53]. 
The OECD and the WHO developed a micro-simulation model to assess the cost-effectiveness of 
seven preventive interventions addressing behavioural risk factors linked with obesity (school based 
health promotion interventions, worksite health promotion interventions, mass media health promotion 
campaigns, fiscal measures to increase the cost of undesirable foods and decrease the cost of desirable 
foods, physician counselling of patients at high risk, the regulation of food advertising to children, and 
compulsory food labelling) [54]. The interventions were assessed against a comparator situation where 
only treatment interventions and no preventive interventions were available in six developing nations 
(Brazil, China, India, Mexico, Russia and South Africa; England was included for comparison) [54]. 
The interventions which were cost-effective (or cost-saving) across all countries were fiscal measures 
and food labelling over the 20 year time horizon; with food advertising joining this group over the 50 year 
time horizon. The authors comment that the characteristics of the more cost-effective interventions 
were that they had a greater coverage of the population and were relatively low cost to implement 
compared to the more targeted interventions assessed [54]. Two further studies using the ACE 
methodology for priority setting are currently being conducted in the USA (CHOICES project) and 
New Zealand (NZ-ACE), however final results from these studies are not yet available [55,56]. 
5. Review of the Evidence Gaps 
To determine the current evidence gaps and to determine whether upstream or downstream 
interventions are the most cost-effective, the ACE interventions have been mapped to the continuum of 
the key determinants and solutions to the obesity epidemic (Figure 1). This continuum spans across 
upstream factors related to economic systems affecting nations to downstream factors affecting the 
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physiology of individuals [1,10,57]. All of the treatment and the majority of the preventive 
interventions investigated thus far are downstream solutions that target predominantly individual 
behaviour and physiology. Amongst the preventive interventions, a further distinction can be made 
between health promotion interventions that target individual behaviour and those that target the 
obesogenic environment. The three preventive interventions that targeted the obesogenic environment 
(reduction of advertising of unhealthy food and beverages to children, front-of-pack traffic light 
nutrition labelling and a 10% tax on unhealthy food and beverages) were all cost-saving. The key 
determinants of their favourable cost-effectiveness profile were the small health impact for the  
whole population resulting in significant DALYs saved, together with a relatively low cost of  
implementation [57]. Off-setting their economic credential, all these interventions rated high on the 
scale of political difficulty surrounding their implementation [1]. The interventions which were found 
to be most cost-effective from the OECD/WHO priority setting exercise [54] can be categorised as 
“environmental drivers” in Figure 1 and are consistent with the findings from the ACE studies. 
Figure 1. Interventions from the Assessing Cost Effectiveness (ACE) Obesity and  
ACE-Prevention studies, mapped to the continuum of obesity determinants and solutions. 
 
 
Although the discipline of economics has contributed to a better understanding of the causes of the 
obesity epidemic and has provided some insights into potential cost-effective options for change,  
Int. J. Environ. Res. Public Health 2014, 11 4019 
 
 
there remain substantial gaps in the evidence base. The current evidence available from previous  
ACE projects and other priority setting exercises related to obesity management suggests that the most 
effective and cost-effective interventions are upstream and target the drivers of the obesogenic 
environment; however the majority of interventions that have been investigated to date are 
downstream. Several obesity commentators [1,10,57] have emphasised the importance of addressing 
not only the environmental drivers of the obesogenic environment, but importantly focusing on the 
systemic drivers of the problem. However there has been very limited investigation of the impact of 
upstream social and economic policies such as taxation, trade, and regulation of the market [1]. 
Learning from the successes of policies related to tobacco control, obesity prevention will require 
the implementation of a range of interventions across several sectors. Although the health sector bares 
a substantial burden related to obesity, policy actions that may have the greatest impact on curtailing 
the obesity epidemic span multiple sectors, such as agriculture, finance, urban planning, and transport [57]. 
Furthermore, there is evidence that the general economy also bares a substantial burden related to 
obesity due to lost productivity and absenteeism [58–60]. It is therefore in the interests of multiple 
sectors to contribute to the solution. Despite this, there is limited effectiveness and cost-effectiveness 
evidence related to interventions in these sectors and there are several challenges involved in economic 
evaluation of upstream obesity prevention policy interventions across various non-health sectors. 
These relate to limited evidence of effectiveness; difficulties in capturing the benefits of an 
intervention across multiple sectors (e.g., public transport policies have an impact on traffic,  
but may also have a health impact related to increased physical activity); assessing the effectiveness of 
several interventions implemented concurrently; incorporating equity impacts into the technical 
economic analyses and aiding the translation of results into effective policy action. 
A recent review of the evidence base for obesity prevention by the Institute of Medicine (USA) 
concluded that there was a striking contrast between the importance of addressing the issue of obesity 
and the lack of a knowledge base to inform decision making on prevention efforts [61].  
Nonetheless, the paucity of evidence need not and should not preclude the making of allocative 
decisions; and if the discipline of economics is to play a significant role in this exercise, it is important 
that quality economic evaluations are undertaken based on the best evidence available which may not 
always equate to the best evidence possible [62]. In order to effectively evaluate interventions which 
do not have RCT evidence, traditional evidence hierarchy frameworks need to be expanded to 
incorporate a variety of secondary evidence sources such as “indirect” and “parallel” evidence.  
While initial work in this area has commenced [61,62], to date there are limited examples of how 
secondary evidence should be incorporated into economic evaluations. 
The ACE studies provide very useful information, but the study perspective focussed on the health 
sector and didn’t capture the full range of benefits for interventions that span or involve other sectors. 
Methodological advancements in economic evaluation are required to capture the systems effects of 
preventive interventions and to capture the full range of inter-sectorial benefits. It is anticipated that 
cost-benefit analysis where all costs and benefits are measured in monetary terms holds promise for 
such evaluations. 
In Australia and in many other developed nations, obesity is most prevalent amongst those in the 
most disadvantaged SES groups [63,64]. Decision makers need information on the equity impacts of 
obesity prevention interventions to understand the potential of policy interventions to broaden or 
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narrow the health gap between the most advantaged and disadvantaged members of society.  
The previous ACE projects considered the equity impacts of interventions qualitatively alongside the 
cost-effectiveness results; however more research is required to ascertain the most appropriate methods 
available to incorporate equity impacts into the technical analyses of an obesity priority setting exercise. 
Further adding to the complexity of evidence-based decision making in obesity prevention is the 
political difficulty involved in implementing interventions that affect the interests of the very powerful 
food industry [57,65]. Priority setting exercises which use a broad societal perspective and explicitly 
consider the financial impact of proposed interventions on the private sector may enhance the ability of 
the results to have a more significant impact on policy decision making. In addition, a key component 
of future priority setting exercises should be the engagement and collaboration with decision makers 
outside the health care sector throughout the evaluation process. 
6. Conclusions 
Economic factors, such as the focus on growth and increasing consumerism is driving increased 
consumption of foods, beverages and energy saving devices, and has produced an obesogenic 
environment where passive over-consumption is pervasive [1]. The economic case for government 
intervention in obesity prevention is strong. The discipline of health economics can assist in resource 
allocation decision making by providing high quality evidence on the cost-effectiveness of a range of 
obesity management interventions. Previous priority setting exercises have made progress in 
advancing the knowledge base related to value-for-money options to curtail the obesity epidemic.  
A review of these studies revealed that interventions aimed at primary prevention were likely to be 
more cost-effective compared to treatment or secondary prevention interventions. In addition,  
policy interventions were found to be more sustainable and therefore more cost-effective than 
programs which require ongoing funding for implementation. Finally, interventions targeting food 
intake (or food intake combined with physical activity) were likely to be more cost-effective than 
interventions only targeting physical activity. The interventions most likely to be cost-effective were 
the upstream interventions that targeted the environmental drivers of the obesity epidemic such as 
regulation related to unhealthy food and beverage advertising, front of pack nutrition labelling and 
taxes on unhealthy food and beverages. However, there are very few interventions that have been 
evaluated in a priority setting context which address the systemic drivers of obesity. 
In order to make a more significant contribution to obesity prevention, future priority setting 
exercises need to focus on upstream interventions, advance current methodologies, and enhance the 
translation of evidence into effective public health policy. In this regards, it is reassuring that there is 
active research which will progress these areas. Examples from Australia include a research program 
led by Deakin University that is investigating the cost-effectiveness of 40 non-health sector 
interventions and aims to incorporate equity impacts into the cost-effectiveness methods [66];  
a research group from the University of Melbourne investigating the cost-effectiveness of several 
interventions related to the built environment [67]; and complementary to both of these projects,  
is work being undertaken by a consortium led by the George Institute for Global Health around 
methodological advancements related to the evaluation of preventive interventions including the 
evaluation of systems effects. 
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